These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
822 related articles for article (PubMed ID: 11148007)
1. Drug targets and mechanisms of resistance in the anaerobic protozoa. Upcroft P; Upcroft JA Clin Microbiol Rev; 2001 Jan; 14(1):150-64. PubMed ID: 11148007 [TBL] [Abstract][Full Text] [Related]
2. In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites. Cedillo-Rivera R; Chávez B; González-Robles A; Tapia A; Yépez-Mulia L J Eukaryot Microbiol; 2002; 49(3):201-8. PubMed ID: 12120985 [TBL] [Abstract][Full Text] [Related]
3. Drug susceptibility testing of anaerobic protozoa. Upcroft JA; Upcroft P Antimicrob Agents Chemother; 2001 Jun; 45(6):1810-4. PubMed ID: 11353630 [TBL] [Abstract][Full Text] [Related]
4. Keto-acid oxidoreductases in the anaerobic protozoa. Upcroft JA; Upcroft P J Eukaryot Microbiol; 1999; 46(4):447-9. PubMed ID: 10461388 [TBL] [Abstract][Full Text] [Related]
5. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis. Adagu IS; Nolder D; Warhurst DC; Rossignol JF J Antimicrob Chemother; 2002 Jan; 49(1):103-11. PubMed ID: 11751773 [TBL] [Abstract][Full Text] [Related]
6. Drug susceptibility testing in microaerophilic parasites: Cysteine strongly affects the effectivities of metronidazole and auranofin, a novel and promising antimicrobial. Leitsch D Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):321-327. PubMed ID: 28910741 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas, and Entamoeba spp. Upcroft JA; Campbell RW; Benakli K; Upcroft P; Vanelle P Antimicrob Agents Chemother; 1999 Jan; 43(1):73-6. PubMed ID: 9869568 [TBL] [Abstract][Full Text] [Related]
8. Current and future perspectives on the chemotherapy of the parasitic protozoa Trichomonas vaginalis and Entamoeba histolytica. Moya IA; Su Z; Honek JF Future Med Chem; 2009 Jul; 1(4):619-43. PubMed ID: 21426030 [TBL] [Abstract][Full Text] [Related]
9. Highly Potent 1 Kumar S; Bains T; Won Kim AS; Tam C; Kim J; Cheng LW; Land KM; Debnath A; Kumar V Front Cell Infect Microbiol; 2018; 8():380. PubMed ID: 30425970 [TBL] [Abstract][Full Text] [Related]
10. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis. Dunne RL; Dunn LA; Upcroft P; O'Donoghue PJ; Upcroft JA Cell Res; 2003 Aug; 13(4):239-49. PubMed ID: 12974614 [TBL] [Abstract][Full Text] [Related]
11. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis]. Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960 [TBL] [Abstract][Full Text] [Related]
12. Trichomonads, hydrogenosomes and drug resistance. Kulda J Int J Parasitol; 1999 Feb; 29(2):199-212. PubMed ID: 10221623 [TBL] [Abstract][Full Text] [Related]
13. The effect of iron on metronidazole activity against Trichomonas vaginalis in vitro. Elwakil HS; Tawfik RA; Alam-Eldin YH; Nassar DA Exp Parasitol; 2017 Nov; 182():34-36. PubMed ID: 28935536 [TBL] [Abstract][Full Text] [Related]
14. Trichomonas vaginalis: metronidazole and other nitroimidazole drugs are reduced by the flavin enzyme thioredoxin reductase and disrupt the cellular redox system. Implications for nitroimidazole toxicity and resistance. Leitsch D; Kolarich D; Binder M; Stadlmann J; Altmann F; Duchêne M Mol Microbiol; 2009 Apr; 72(2):518-36. PubMed ID: 19415801 [TBL] [Abstract][Full Text] [Related]
15. 5-Nitroimidazole drugs effective against metronidazole-resistant Trichomonas vaginalis and Giardia duodenalis. Upcroft JA; Dunn LA; Wright JM; Benakli K; Upcroft P; Vanelle P Antimicrob Agents Chemother; 2006 Jan; 50(1):344-7. PubMed ID: 16377707 [TBL] [Abstract][Full Text] [Related]
16. Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis. Jarrad AM; Debnath A; Miyamoto Y; Hansford KA; Pelingon R; Butler MS; Bains T; Karoli T; Blaskovich MA; Eckmann L; Cooper MA Eur J Med Chem; 2016 Sep; 120():353-62. PubMed ID: 27236016 [TBL] [Abstract][Full Text] [Related]
17. High rates of double-stranded RNA viruses and Mycoplasma hominis in Trichomonas vaginalis clinical isolates in South Brazil. da Luz Becker D; dos Santos O; Frasson AP; de Vargas Rigo G; Macedo AJ; Tasca T Infect Genet Evol; 2015 Aug; 34():181-7. PubMed ID: 26160539 [TBL] [Abstract][Full Text] [Related]
18. Activity of methylgerambullin from Glycosmis species (Rutaceae) against Entamoeba histolytica and Giardia duodenalis in vitro. Drinić M; Raninger A; Zraunig A; Astelbauer F; Leitsch D; Obwaller A; Walochnik J; Greger H; Duchene M Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():109-117. PubMed ID: 31472356 [TBL] [Abstract][Full Text] [Related]
19. Genetic Indicators of Drug Resistance in the Highly Repetitive Genome of Trichomonas vaginalis. Bradic M; Warring SD; Tooley GE; Scheid P; Secor WE; Land KM; Huang PJ; Chen TW; Lee CC; Tang P; Sullivan SA; Carlton JM Genome Biol Evol; 2017 Jun; 9(6):1658-1672. PubMed ID: 28633446 [TBL] [Abstract][Full Text] [Related]
20. A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in Graves KJ; Novak J; Secor WE; Kissinger PJ; Schwebke JR; Muzny CA Parasitology; 2020 Nov; 147(13):1383-1391. PubMed ID: 32729451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]